|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Neothetics, Inc.
| | | Phone: | (858) 750-1008 | Fax: | (858) 750-1013 | Year Established: | 2007 | Ticker: | NEOT | Exchange: | NASDAQ | Main Contact: | Saundra Pelletier, CEO | | Other Contacts: | Maria Feldman, VP, Clinical Research & Operations, and RA/QA Kenneth W. Locke, Ph.D., CSO
| | Company Description | Neothetics, formerly Lipothera, is a specialty pharmaceutical company developing a first-in-class injectable product that has the potential to expand the global body contouring aesthetic market. Phase 3-ready LIPO-202 is for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. The company’s pipeline also includes clinical stage LIPO-102 for the protrusion of the eye associated with thyroid disease caused by expansion of fat and muscle behind the eye. | |
|
|
|
|
|